Inventor
Henry Perry Fell, Jr.
Inventor
Redmond, WA, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides31%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C12NMicroorganisms or enzymes13%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
PatentTitleYear
7,915,395'Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell'20117,824,683'Methods for augmenting an immune response using anti-CD40 antibodies'20107,666,422'Methods for the treatment of cancer using anti-CD40 antibodies'20107,510,711'Methods for the treatment of cancer using anti-CD40 antibodies'20097,498,032'Methods for treating immune disorders or cancer with anti-CD40 antibodies'20096,946,129'Recombinant anti-CD40 antibody and uses thereof'20056,843,989'Methods for the treatment and prevention of cancer using anti-CD40 antibodies'20056,838,261'Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins'20056,482,919'Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell'20026,132,992'Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell'20005,709,859'Mixed specificity fusion proteins'19985,645,835'Therapeutic antibody based fusion proteins'19975,637,481'Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell'19975,482,856'Production of chimeric antibodies by homologous recombination'19965,314,995'Therapeutic interleukin-2-antibody based fusion proteins'19945,204,244'Production of chimeric antibodies by homologous recombination'19935,202,238'Production of chimeric antibodies by homologous recombination'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–1997Patents assigned to ONCOGEN (4)· patent assignee history
1993–2011Based in Redmond, WA, US· patent location history
1996Patents assigned to ONCOGEN INC (1)· patent assignee history
1997–2011Patents assigned to BRISTOL MYERS SQUIBB CO (5)· patent assignee history
2005–2010Patents assigned to SEATTLE GENETICS INC (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SEATTLE GENETICS INC | 7 | 2005–2010 |
| BRISTOL MYERS SQUIBB CO | 5 | 1997–2011 |
| ONCOGEN | 4 | 1993–1997 |
| ONCOGEN INC | 1 | 1996 |
Locations
| Location | Patents | Span |
|---|---|---|
| Redmond, Washington, US | 17 | 1993–2011 |